AzurRx BioPharma

$0.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.001 (+0.13%) Today
+$0.0189 (+2.42%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AZRX and other stocks, options, and ETFs commission-free!

About AZRX

AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It focuses on MS1819-SD, and B-Lactamase program products. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY. The listed name for AZRX is AzurRx BioPharma, Inc. Common Stock.

CEO
James E. Sapirstein, MBA
Employees
10
Headquarters
Brooklyn, New York
Founded
2014
Market Cap
22.56M
Price-Earnings Ratio
Dividend Yield
Average Volume
178.21K
High Today
$0.80
Low Today
$0.78
Open Price
$0.80
Volume
82.82K
52 Week High
$1.94
52 Week Low
$0.3709

Collections

AZRX Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.46 per share

You May Also Like